NCP, a Dual Kappa and Mu Opioid Receptor Agonist, Is a Potent Analgesic Against Inflammatory Pain without Reinforcing or Aversive Properties
The Journal of Pharmacology and Experimental Therapeutics · 2024-04 · 389 (1) · 106-117
DOI: 10.1124/jpet.123.001870 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pharmacology and Experimental Therapeutics, 2024-04. Verfasst von Peng Huang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center for Substance Abuse Research, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania (P.H., C.K.H., D.C., S.I., S.M.R., L…. Hauptthemen laut MEDLINE: Receptors, Opioid, kappa, Receptors, Opioid, mu, Inflammation, Pain. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS.
Abstract (Originalsprache)
While agonists of μ (MOR) and κ (KOR) opioid receptors have analgesic effects, they produce euphoria and dysphoria, respectively. Other side effects include respiratory depression and addiction for MOR agonists and sedation for KOR agonists. We reported that 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-{[4'-(2'-cyanopyridyl)]carboxamido}morphinan (NCP) displayed potent KOR full agonist and MOR partial agonist activities (58%) with 6.5x KOR-over-MOR selectivity in vitro. Herein, we characterized pharmacological effects of NCP in rodents. In mice, NCP exerted analgesic effects against inflammatory pain in both the formalin test and the acetic acid writhing test, with A50 values of 47.6 and 14.4 μg/kg (s.c.), respectively. The analgesic effects in the acetic acid writhing test were mediated by the KOR. NCP at doses much higher than those effective in reducing inflammatory pain did not produce antinociception in the hot plate and tail flick tests, inhibit compound 48/80-induced scratching, cause conditioned place aversion (CPA) or preference, impair rotarod performance, inhibit locomotor activity, cause respiratory depression, or precipitate morphine withdrawal. However, NCP (10∼100 μg/kg) inhibited gastrointestinal transit with a maximum of ∼40% inhibition. In MOR knockout mice, NCP caused CPA, demonstrating that its lack of CPA is due to combined actions on the MOR and KOR. Following subcutanous injection, NCP penetrated into the mouse brain. In rats trained to self-administer heroin, NCP (1∼320 μg/kg/infusion) did not function as a reinforcer. Thus, NCP produces potent analgesic effects via KOR without side effects except constipation. Therefore, dual full KOR/partial MOR agonists with moderate KOR-over-MOR selectivity may be promising as nonaddictive analgesics for inflammatory pain. SIGNIFICANCE STATEMENT: Developing nonaddictive analgesics is crucial for reducing opioid overdose deaths, minimizing drug misuse, and promoting safer pain management practices. Herein, the pharmacology of a potential nonaddictive analgesic, NCP, is reported. NCP has full KOR agonist/partial MOR agonist activities with a 6.5x selectivity for KOR over MOR. Unlike MOR agonists, analgesic doses of NCP do not lead to self-administration or respiratory depression. Furthermore, NCP does not produce aversion, hypolocomotion, or motor incoordination, side effects typically associated with KOR activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Substance Abuse Research, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania (P.H., C.K.H., D.C., S.I., S.M.R., L.-Y.L.-C.); Departments of Medicinal Chemistry (M.L., B.H., P.P.P., Y.…
Förderung
- NIDA NIH HHS
Zitieren
APA
Huang, P., Ho, C. K., Cao, D., Inan, S., Rawls, S. M., Li, M., Huang, B., Pagare, P. P., Townsend, E. A., Poklis, J. L., Halquist, M. S., Banks, M., Zhang, Y., & Liu-Chen, L. Y. (2024). NCP, a Dual Kappa and Mu Opioid Receptor Agonist, Is a Potent Analgesic Against Inflammatory Pain without Reinforcing or Aversive Properties. The Journal of Pharmacology and Experimental Therapeutics, 389(1), 106-117. https://doi.org/10.1124/jpet.123.001870
Vancouver
Huang P, Ho CK, Cao D, Inan S, Rawls SM, Li M, et al. NCP, a Dual Kappa and Mu Opioid Receptor Agonist, Is a Potent Analgesic Against Inflammatory Pain without Reinforcing or Aversive Properties. The Journal of Pharmacology and Experimental Therapeutics. 2024;389(1):106-117. doi:10.1124/jpet.123.001870
BibTeX
@article{Huang2024,
author = {Huang, Peng and Ho, Conrad K and Cao, Danni and Inan, Saadet and Rawls, Scott M and Li, Mengchu and Huang, Boshi and Pagare, Piyusha P and Townsend, E Andrew and Poklis, Justin L and Halquist, Matthew S and Banks, Matthew and Zhang, Yan and Liu-Chen, Lee-Yuan},
title = {NCP, a Dual Kappa and Mu Opioid Receptor Agonist, Is a Potent Analgesic Against Inflammatory Pain without Reinforcing or Aversive Properties},
journal = {The Journal of Pharmacology and Experimental Therapeutics},
year = {2024},
volume = {389},
number = {1},
pages = {106--117},
doi = {10.1124/jpet.123.001870}
}
EUVIMED